Dr. James Lim and Lakshana Sreenivasan discovered that certain immune signals may help medulloblastoma resist chemotherapy
On Dec. 5, 2020, Dr. James Lim and Lakshana Sreenivasan discovered that certain immune signals may help medulloblastoma…
On Dec. 5, 2020, Dr. James Lim and Lakshana Sreenivasan discovered that certain immune signals may help medulloblastoma…
On Dec. 4, 2020, researchers at the National Institutes of Health reported that they had made a surprising…
On Dec. 4, 2020, Novo Nordisk announced that the FDA approved an updated label for Saxenda (liraglutide) injection…
On Dec. 4, 2020, the FDA authorized the first diagnostic test for at home collection of patient samples…
On Dec. 4, 2020, it was reported in JAMA that high-dose influenza (commonly known as flu) vaccines are…
On Dec. 4, 2020, Los Angeles County launched a new COVID-19 home test collection program, which allowed certain…
On Dec. 4, 2020, Eli Lilly and UnitedHealth Group announced a partnership to conduct a pragmatic study of…
On Dec. 4, 2020, VBI Vaccines and Syneos Health announced a partnership for the commercialization of VBIï¾’s 3-antigen…
On Dec. 3, 2020, the U.S. Department of Defense in coordination with the Department of HHS, awarded a…
On Dec. 3, 2020, the Advisory Committee on Immunization Practices (ACIP) recommended, as interim guidance, that both 1)…
On Dec. 3, 2020, a new study by researchers at the University of British Columbia and BC Children’s…
On Dec. 3, 2020, Moderna announced in a letter to the editor published in the New England Journal…
On Dec. 3, 2020, AXIM Biotechnologies announced the development and patent filing for an enzyme-linked immunosorbent assay (ELISA)-based…
On Dec. 3, 2020, Meridian Bioscience announced that it had launched an Air-Dryable RT-qPCR Mix, driving innovation in…
On Dec. 3, 2020, Inovio Pharmaceuticals announced the execution of an agreement with Kaneka Eurogentec an affiliate of…
On Dec. 3, 2020, a team led by UT Southwestern announced that it had derived a new モintermediateï¾”…
On Dec. 2, 2020, Roche announced that its Elecsysï¾® Anti-SARS-CoV-2 S antibody test had received Emergency Use Authorization…
On Dec. 2, 2020, Oxford Immunotec announces an exclusive distribution agreement with RIKEN Genesis in Japan. Under the…
On Dec. 2, 2020, the first COVID-19 vaccine for the UK, developed by Pfizer/BioNTech, was given approval for…
On Dec. 2, 2020, Codex DNA announced the release of seven new synthetic SARS-CoV-2 genomes for use in…
On Dec. 2, 2020, Eli Lilly announced that the U.S. government had purchased 650,000 additional doses of the…
On Dec. 2, 2020, BD (Becton, Dickinson) announced plans to invest approximately $1.2 billion over a 4-year period…
On Dec. 2, 2020, Pfizer and BioNTech announced that the Medicines & Healthcare Products Regulatory Agency (MHRA) in…
On Dec. 2, 2020, the University of Oregon opened the Phil and Penny Knight Campus for Accelerating Scientific…
On Dec. 1, 2020, the FDA approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) ï¾– the first drug for…
On Dec. 1, 2020, the U.S. Department of Defense announced awards to 150 university researchers totaling $50 million…
On Dec. 1, 2020, Pfizer and BioNTech announced they had submitted on Nov. 30, 2020, a formal Application…
On Dec. 1, 2020, VBI Vaccines announced the submission of a Biologics License Application (BLA) to the FDA…
On Nov. 25, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes…
On Nov. 30, 2020, Jaguar Health subsidiary, Napo Pharmaceuticals, announced that Jaguar and Napo are planning to develop…